138 related articles for article (PubMed ID: 8195324)
41. Stability of urinary HVA and VMA on filter paper.
Cyr D; Giguère R; Tuchman M; Lemieux B
Early Hum Dev; 1997 Sep; 49(2):149-52. PubMed ID: 9226122
[TBL] [Abstract][Full Text] [Related]
42. Mass screening for neuroblastoma in Miyagi Prefecture.
Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
[TBL] [Abstract][Full Text] [Related]
43. Does N-myc amplification correlate with other prognostic factors in advanced neuroblastoma? Preliminary results.
Verdona G; Garaventa A; Coviello DA; Sansone R; Cornaglia-Ferraris P; Tonini GP
Pediatr Hematol Oncol; 1986; 3(4):367-9. PubMed ID: 3153250
[No Abstract] [Full Text] [Related]
44. Serial studies of serum dopamine-B-hydroxylase and urinary vanillylmandelic and homovanillic acids in neuroblastoma.
Brewster MA; Berry DH
Med Pediatr Oncol; 1979; 6(2):93-9. PubMed ID: 460046
[TBL] [Abstract][Full Text] [Related]
45. Urinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children's neuroblastic tumors.
Izbicki T; Bozek J; Perek D; Wozniak W
J Pediatr Surg; 1991 Oct; 26(10):1230-4. PubMed ID: 1779334
[TBL] [Abstract][Full Text] [Related]
46. HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid.
Lionetto L; Lostia AM; Stigliano A; Cardelli P; Simmaco M
Clin Chim Acta; 2008 Dec; 398(1-2):53-6. PubMed ID: 18760269
[TBL] [Abstract][Full Text] [Related]
47. [Vanillylmandelic acid (VMA) and homovanillic acid (HVA)].
Kanesaka Y; Tomita K
Nihon Rinsho; 1999 Dec; 57 Suppl():223-5. PubMed ID: 10778106
[No Abstract] [Full Text] [Related]
48. Urinary creatinine adjusted reference ranges for homovanillic and vanillylmandelic acid in children and adults.
Cole M; Craft AW; Parker L; Bell S; Seviour JA; McGill AC; Dale G
Clin Chim Acta; 1995 Apr; 236(1):19-32. PubMed ID: 7664463
[TBL] [Abstract][Full Text] [Related]
49. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
50. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
51. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
Berthold F; Hunneman DH; Harms D; Käser H; Zieschang J
Eur J Cancer; 1992; 28A(12):1950-4. PubMed ID: 1419287
[TBL] [Abstract][Full Text] [Related]
52. The prognostic significance of vanillylmandellic acid in neuroblastoma.
Aydin GB; Kutluk MT; Yalcin B; Varan A; Akyuz C; Buyukpamukcu M
Pediatr Hematol Oncol; 2010 Sep; 27(6):435-48. PubMed ID: 20578806
[TBL] [Abstract][Full Text] [Related]
53. Catecholamine metabolites in ganglioneuroma.
Lucas K; Gula MJ; Knisely AS; Virgi MA; Wollman M; Blatt J
Med Pediatr Oncol; 1994; 22(4):240-3. PubMed ID: 8107654
[TBL] [Abstract][Full Text] [Related]
54. Bilateral adrenal neuroblastoma.
Ishiguro Y; Iio K; Seo T; Nagaya M; Ito T
Eur J Pediatr Surg; 1994 Feb; 4(1):37-9. PubMed ID: 8199131
[TBL] [Abstract][Full Text] [Related]
55. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
[No Abstract] [Full Text] [Related]
56. False positive results in a neuroblastoma screening programme.
Bell S; Parker L; Craft AW; Dale G; McGill AC; Seviour J; Cole M; Smith J
Med Pediatr Oncol; 1994; 22(3):181-6. PubMed ID: 8272007
[TBL] [Abstract][Full Text] [Related]
57. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Simon T; Hero B; Hunneman DH; Berthold F
Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
[TBL] [Abstract][Full Text] [Related]
58. Studies on tyrosine hydroxylase in neuroblastoma in relation to urinary levels of catecholamine metabolites.
Imashuku S; Takada H; Sawada T; Nakamura T; LaBrosse EH
Cancer; 1975 Aug; 36(2):450-7. PubMed ID: 239788
[TBL] [Abstract][Full Text] [Related]
59. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
[TBL] [Abstract][Full Text] [Related]
60. Problems of mass screening for neuroblastoma: analysis of false-negative cases.
Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
J Pediatr Surg; 1990 Apr; 25(4):398-401. PubMed ID: 2329455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]